About FRUZAQLA®

Learn more about FRUZAQLA®, a targeted therapy for patients with metastatic colorectal cancer (mCRC)

Blog Post

More

2 min

FRESCO-2 study design

Learn more about FRESCO-2, an international, randomised, double-blind, placebocontrolled, multicentre phase 3 study

Blog Post

More

3 min

Efficacy

Explore the efficacy data of the pivotal trial FRESCO-2

Blog Post

More

6 min

Safety profile

Explore the safety data of the pivotal trial FRESCO-2

Blog Post

More

6 min

Quality of life

Explore the data on quality of life of the pivotal trial FRESCO-2

Blog Post

More

3 min

Dosing

Once-daily oral dosing with FRUZAQLA®

Blog Post

More

2 min

Join us for an engaging and interactive session focused on advancing CMV management in solid organ transplant (SOT) recipients. The event will feature expert insights from Prof. Dr. Dionysios Neofytos and Prof. Dr. Nikolaus Kneidinger and offers a unique opportunity to explore the latest data and its practical application in clinical settings.

Where

SpotMe platform

Subscribe to